Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2012
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101756016B Natural plant preparation for preventing animal diarrhea and preparation method thereof
09/05/2012CN101745042B Composition with effects of relieving alcoholism and protecting liver and preparation method thereof
09/05/2012CN101744830B Flavonoid compound and application of plant extract containing same
09/05/2012CN101732466B Method for controlling quality of Guipi granules
09/05/2012CN101721613B Composition for enhancing constitution and preparation method thereof
09/05/2012CN101721507B Composition for relieving and treating fatty livers and preparation method thereof
09/05/2012CN101716179B Anti-hepatitis B pharmaceutical composition, preparation method and applications thereof
09/05/2012CN101626779B Oral disinfectant, food additive comprising the disinfectant
09/05/2012CN101623366B Composition for curing gastrointestinal functional disorders, preparation method thereof and application thereof in preparing drugs for curing gastrointestinal functional disorders
09/05/2012CN101590108B Method for changing viscosity of Magnolia extract
09/05/2012CN101569735B Traditional Chinese medicine for treating chronic superficial gastric, digestive ulcer
09/05/2012CN101563092B A composition comprising the extract of combined herbs for preventing and treating liver disease
09/05/2012CN101538520B Tricholoma matsutake wine
09/05/2012CN101496809B Application of forsythiaside B in preparing medicament for treating or preventing acute and chronic liver damnification and liver fibrosis
09/05/2012CN101375837B Medicament composition for treating dermatopathy as well as preparation method and use thereof
09/05/2012CN101360508B Pharmaceutical composition, food or drink, or feed for intestinal disease
09/05/2012CN101284003B Medicinal composition containing andrographolide derivatives and preparation method thereof and application
09/05/2012CN101180291B Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists
09/05/2012CN101168560B N-substituted peptide amide, pharmaceutical composition and use thereof
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258142 Substituted 8-[6-amino-3-pyridyl]xanthines
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258122 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012CA2351982C Selection and uses of lactic acid bacteria strains modulating non-specific immunity
08/2012
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012115480A2 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012WO2012115479A2 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012WO2012115478A2 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115066A1 Glycine transport inhibitor
08/30/2012WO2012114317A1 Novel rebamipide complexes and cocrystals
08/30/2012WO2012114268A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012WO2012114131A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
08/30/2012WO2012113850A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
08/30/2012WO2012113236A1 Use and method of hepatocyte nuclear factor 1α for treating chronic liver diseases
08/30/2012WO2012113113A1 Herbal composition and use thereof
08/30/2012WO2012113103A1 Asymmetric ureas and medical uses thereof
08/30/2012WO2012113037A1 Method for inhibiting proteins
08/30/2012WO2012092157A3 Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
08/30/2012WO2012067437A3 Composition for increasing liver volume for the purpose of liver resection
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120220666 Composition to enhance the bioavailability of curcumin
08/30/2012US20120220659 Medicament having promoting action on hepatocyte proliferation
08/30/2012US20120220654 Therapeutic solution concentrate
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220623 The enantiomer of tenatoprazole and the use thereof in therapy
08/30/2012US20120220608 Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
08/30/2012US20120220606 New capped pyrazinoylguanidine sodium channel blockers
08/30/2012US20120220602 Cysteine protease inhibitors
08/30/2012US20120220592 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
08/30/2012US20120220589 Heterocyclic compounds for the inhibition of pask
08/30/2012US20120220587 Pyridinylimidazolone derivatives for the inhibition of pi3 kinases
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220575 N-substituted oxazinopteridines and oxazinopteridinones
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220546 Compostions designed for the inhibition and/or blocking of the epithelial/mesenchymal transition
08/30/2012US20120220526 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and other Disorders
08/30/2012US20120219648 Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry
08/30/2012US20120219642 Colon cleansing of residual stool and secretions during colonoscopy
08/30/2012US20120219641 5-ht3 receptor modulators, methods of making, and use thereof
08/30/2012US20120219627 Compositions and improved soft tissue replacement methods
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219612 Mineral Technologies (MT) for Acute Hemostasis and for the Treatment of Acute Wounds and Chronic Ulcers
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219581 Methods and formulations for treating chronic liver disease
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219527 Compositions for reducing gastro-intestinal methanogenesis in ruminants
08/30/2012US20120219526 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
08/30/2012US20120219525 Stable thickener formulations
08/30/2012US20120219505 Peptide reagents and methods for detection of colon dysplasia
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2827072A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2827030A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012CA2824350A1 (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2491951A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
08/29/2012EP2490699A1 Oral delivery of therapeutically effective lna oligonucleotides
08/29/2012CN102649814A Earthworm protein with HBeAg degrading enzyme activity and application thereof
08/29/2012CN102649788A Beta-L-2'-desoxy-thymin-nucleoside derivative, preparation method and purposes thereof
08/29/2012CN102648980A Colonic purgative composition with soluble binding agent
08/29/2012CN102648978A Stable protein pharmaceutical preparation and preparation method thereof
08/29/2012CN102648973A Combinatorial drug for treating gastrointestinal tract diseases
08/29/2012CN102648962A Medicine for treating gastrointestinal diseases
08/29/2012CN102648957A Traditional Chinese medicine for treating kidney disease and kidney deficiency
08/29/2012CN102648928A Berberis amurensis Rupr. tincture
08/29/2012CN102648927A Production technology of petasites lactone compound
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 1258